
MinnPost thanks these major sponsors:
Sponsor of
Second Opinion
Sponsor of
Community Sketchbook
Our major advertisers
Our in-kind partners

MinnPost thanks these generous donors:
INDIVIDUALS AND FOUNDATI0NS
Blandin Foundation
Otto Bremer Foundation
Bush Foundation
Sage & John Cowles
David & Vicki Cox
Toby & Mae Dayton
Jack & Claire Dempsey
Ethics and Excellence in Journalism Foundation
Sam & Stacey Heins
John S. and James L. Knight Foundation
Joel & Laurie Kramer
Lee Lynch & Terry Saario
Martin & Brown Foundation
The McKnight Foundation
The Minneapolis Foundation
The Saint Paul Foundation
Rebecca & Mark Shavlik
(See all donors here.)
By Dan Haugen | Published Mon, Sep 21 2009 2:44 pm
Medtronic says its Endeavor drug-coated stent outperformed the Boston Scientific's Taxus stent in a three-year clinical trial. The study, however, compared an older generation of the Taxus stent.
The study results were announced at a cardiovascular conference today. They show the Endeavor is measurably safer than the Taxus, though the study found "no difference in efficacy" during the three years in which patients were followed. The trial involved 1,548 patients.
A Boston Scientific spokesman, Paul Donovan, said in an e-mail: "It's important to keep in mind that the Boston Scientific stent used in the Endeavor 4 trial was the first-generation TAXUS Express stent, which has been replaced by the second-generation TAXUS Liberte stent."
Meanwhile, Medtronic also released research data related to its Resolute stent, which showed 1.6 percent of patients required repeat procedures but none experienced blood clots within the stents.
Like what you just read? Support high-quality journalism in Minnesota by becoming a member of MinnPost.
0 Comments:
Forgot Password? | Register to Comment
MinnPost does not permit the use of foul language, personal attacks or the use of language that may be libelous or interpreted as inciting hate or sexual harassment. User comments are reviewed by moderators to ensure that comments meet these standards and adhere to MinnPost's terms of use and privacy policy.
We intend for this area to be used by our readers as a place for civil, thought-provoking and high-quality public discussion. In order to achieve this, MinnPost requires that all commenters register and post comments with their actual names and place of residence. Register here to comment.